^
BIOMARKER:

HER-2 positive

i
Other names: ERBB2, CD340, HER-2, HER2, NEU, NGL, V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
HER-2 positive
Colorectal Cancer
trastuzumab + tucatinib
Sensitive
:
B
Seagen Press Release - 1 week - (New B)
HER-2 positive
HER2 Positive Breast Cancer
MAM-06.301
Sensitive
:
D
Cancer Cell Int - 1 week - (New D)
HER-2 positive
HER2 Positive Breast Cancer
trastuzumab + pyrotinib
Sensitive
:
B
ESMO 2022 - 3 weeks - (New B)
HER-2 positive
Gastric Cancer
KN046 + KN026
Sensitive
:
C3
ESMO 2022 - 3 weeks - (New C3)
HER-2 positive
Gastroesophageal Junction Adenocarcinoma
KN046 + KN026
Sensitive
:
C3
ESMO 2022 - 3 weeks - (New C3)
HER-2 positive
HER2 Positive Breast Cancer
trastuzumab + tucatinib
Sensitive
:
A1
HER-2 positive
HER2 Positive Breast Cancer
trastuzumab + pertuzumab
Sensitive
:
A1
HER-2 positive
HER2 Positive Breast Cancer
margetuximab
Sensitive
:
A1
HER-2 positive
Gastroesophageal Junction Adenocarcinoma
trastuzumab
Sensitive
:
A1
HER-2 positive
HER2 Positive Breast Cancer
fam-trastuzumab deruxtecan-nxki
Sensitive
:
A1
HER-2 positive
Gastric Cancer
fam-trastuzumab deruxtecan-nxki
Sensitive
:
A1
HER-2 positive
Gastroesophageal Junction Adenocarcinoma
fam-trastuzumab deruxtecan-nxki
Sensitive
:
A1
HER-2 positive
HER2 Positive Breast Cancer
ado-trastuzumab emtansine
Sensitive
:
A1
HER-2 positive
HER2 Positive Breast Cancer
trastuzumab
Sensitive
:
A1
HER-2 positive
Gastric Cancer
pembrolizumab + trastuzumab
Sensitive
:
A1
HER-2 positive
HER2 Positive Breast Cancer
pertuzumab / trastuzumab / hyaluronidase-zzxf
Sensitive
:
A1
HER-2 positive
Gastroesophageal Junction Adenocarcinoma
trastuzumab-qyyp
Sensitive
:
A1
HER-2 positive
Gastroesophageal Junction Adenocarcinoma
trastuzumab-dttb
Sensitive
:
A1
HER-2 positive
Gastroesophageal Junction Adenocarcinoma
trastuzumab-dkst
Sensitive
:
A1
HER-2 positive
Gastroesophageal Junction Adenocarcinoma
trastuzumab-anns
Sensitive
:
A1
HER-2 positive
Gastroesophageal Junction Adenocarcinoma
trastuzumab-pkrb
Sensitive
:
A1
HER-2 positive
HER2 Positive Breast Cancer
neratinib
Sensitive
:
A1
HER-2 positive
Salivary Gland Cancer
trastuzumab
Sensitive
:
A1
HER-2 positive
Gastroesophageal Junction Adenocarcinoma
Zercepac (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 positive
HER2 Positive Breast Cancer
Zercepac (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 positive
Gastric Cancer
Zercepac (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 positive
Gastroesophageal Junction Adenocarcinoma
pembrolizumab + trastuzumab
Sensitive
:
A1
HER-2 positive
Colorectal Cancer
trastuzumab + pertuzumab
Sensitive
:
A1
HER-2 positive
Gastric Cancer
trastuzumab
Sensitive
:
A2
HER-2 positive
HER2 Positive Breast Cancer
THP
Sensitive
:
A2
HER-2 positive
HER2 Positive Breast Cancer
TCHP
Sensitive
:
A2
HER-2 positive
HER2 Positive Breast Cancer
trastuzumab + abemaciclib
Sensitive
:
A2
HER-2 positive
HER2 Positive Breast Cancer
TCH
Sensitive
:
A2
HER-2 positive
HER2 Positive Breast Cancer
trastuzumab + lapatinib
Sensitive
:
A2
HER-2 positive
Gastroesophageal Cancer
trastuzumab
Sensitive
:
A2
HER-2 positive
Esophageal Adenocarcinoma
trastuzumab
Sensitive
:
A2
HER-2 positive
Endometrial Cancer
trastuzumab
Sensitive
:
A2